Examining skin responses to UV light in day and night shift workers
Official title: Pilot Study on DNA Repair Activity in the Skin of Day and Night Shift Workers
Run by Wright State University · NCT04122456 · Data updated 2026-11-12
This study tests how the skin of night shift workers reacts to UV light compared to day shift workers to see if their different schedules affect skin health and cancer risk.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | All |
| Enrollment | 48 (estimated) |
| Sponsor | Wright State University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Fairborn, Ohio) |
| Status | Recruiting |
| Started | December 7, 2022 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | July 17, 2026 |
| Trial ID | NCT04122456 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are fair-skinned individuals aged 18 to 40 who work primarily during the day or night shifts.
✕Probably not a fit
Patients with known photosensitivity, diabetes, or a history of skin cancers may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates how the skin of night shift workers reacts to artificial sunlight, specifically ultraviolet B (UVB) radiation, compared to day shift workers. Participants will undergo skin biopsies, which will then be exposed to UVB in a laboratory setting to measure the skin's response. The research aims to understand the potential differences in DNA repair activity in the skin based on work schedules. This could provide insights into skin cancer risks associated with different work shifts.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and prevention strategies for skin cancer in shift workers.
How similar studies have gone: While there is limited information on similar studies, the investigation of UVB responses in different populations is a relevant area of research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male/Female * Fair skin (Fitzpatrick types I and II) * Age 18 to 40 * Able to comprehend procedures/risks * Primarily work and are awake during normal daylight hours (6 am to 6 pm), or primarily work and are awake during night shifts hours (between the hours of 6 pm and 6 am) or may work a mixture of these shifts over the past 3 months. Rotating shifts will be categorized based on the majority of hours worked on average during the last 3 months. Able to fill out a 3-month calendar of work schedule. Exclusion Criteria: * Known photosensitivity * Currently on photosensitizing medications * Diabetes Mellitus * On any hormonal agents (e.g., birth control pills) * History of abnormal scarring * History of skin infections * History of skin cancers * History of sleep disorders such as sleep apnea or insomnia * Known allergy to lidocaine local anesthetic * Pregnancy or nursing * Other serious health issues
Where it's running
-
Wright State Physicians
Fairborn, Ohio, United States Recruiting
Study contacts
- Principal investigator: Jeffrey B Travers, MD, PhD — Wright State University
- Study coordinator: Manager, Clinical Research Operations
- Email: pturesearch@wrightstatephysicians.org
- Phone: 937-245-7500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mobile sun protection support to help young adults stay safe in the sun
This project tests a mobile health program to see if reminders, education, planning tools, and real-time sun exposure information can help young adults protect their skin from excessive sun exposure.
-
Psycho-physiological profiling of people with low versus high heat resilience
This project will test whether controlled heat and UV exposures plus physiological and psychological measurements can identify healthy adults who are more or less resilient to heat.
-
Cosibelimab for tough CSCC in kidney transplant recipients or blood cancers
This trial tests cosibelimab in people with advanced cutaneous squamous cell carcinoma who have a kidney transplant or certain blood cancers to see if it is safe and helpful for them.
-
First-line immunotherapy and PD-L1 testing for metastatic melanoma in Slovenia
This study will see if first-line immunotherapy (pembrolizumab, nivolumab, or ipilimumab plus nivolumab) works for adults in Slovenia with metastatic melanoma and whether PD-L1 measurements predict who responds.
-
Optical and multi-modal analysis to help diagnose skin cancer
This project tests whether combining optical spectroscopy and imaging data from skin samples can help diagnose skin cancer in people with skin concerns.
-
Early skin tumor detection with telemedicine in primary care
This project will test whether a telemedicine tool used by general practitioners can help detect suspicious skin lesions earlier in people with fair skin in the Czech Republic.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.